ATE244889T1 - Assay für spezifische stämme von mit mehreren krankheiten zusammenhängenden proteinkonformationen - Google Patents
Assay für spezifische stämme von mit mehreren krankheiten zusammenhängenden proteinkonformationenInfo
- Publication number
- ATE244889T1 ATE244889T1 AT99906769T AT99906769T ATE244889T1 AT E244889 T1 ATE244889 T1 AT E244889T1 AT 99906769 T AT99906769 T AT 99906769T AT 99906769 T AT99906769 T AT 99906769T AT E244889 T1 ATE244889 T1 AT E244889T1
- Authority
- AT
- Austria
- Prior art keywords
- protein
- amount
- determining
- sample
- disease
- Prior art date
Links
- 102000004169 proteins and genes Human genes 0.000 title abstract 10
- 108090000623 proteins and genes Proteins 0.000 title abstract 10
- 201000010099 disease Diseases 0.000 title abstract 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract 6
- 238000003556 assay Methods 0.000 title abstract 2
- 235000019419 proteases Nutrition 0.000 abstract 6
- 108091005804 Peptidases Proteins 0.000 abstract 5
- 239000004365 Protease Substances 0.000 abstract 5
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 abstract 5
- 238000011534 incubation Methods 0.000 abstract 3
- 241000208465 Proteaceae Species 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
- G01N2800/2814—Dementia; Cognitive disorders
- G01N2800/2828—Prion diseases
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Pathology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- General Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US2695798A | 1998-02-20 | 1998-02-20 | |
| US15105798A | 1998-09-10 | 1998-09-10 | |
| PCT/US1999/002580 WO1999042829A1 (en) | 1998-02-20 | 1999-02-05 | Assay for specific strains of multiple disease related conformations of a protein |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE244889T1 true ATE244889T1 (de) | 2003-07-15 |
Family
ID=26701861
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT99906769T ATE244889T1 (de) | 1998-02-20 | 1999-02-05 | Assay für spezifische stämme von mit mehreren krankheiten zusammenhängenden proteinkonformationen |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP1057022B1 (de) |
| JP (1) | JP2003519357A (de) |
| KR (1) | KR20010041135A (de) |
| AT (1) | ATE244889T1 (de) |
| AU (1) | AU753331B2 (de) |
| BR (1) | BR9908059A (de) |
| CA (1) | CA2318477A1 (de) |
| DE (2) | DE69909442T2 (de) |
| ES (1) | ES2203073T3 (de) |
| WO (1) | WO1999042829A1 (de) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6620629B1 (en) | 1997-02-21 | 2003-09-16 | The Regents Of The University Of California | Method for detecting prions |
| US6617119B2 (en) | 1997-02-21 | 2003-09-09 | The Regents Of The University Of California | Assay for specific strains of multiple disease related conformations of a protein |
| US6221614B1 (en) | 1997-02-21 | 2001-04-24 | The Regents Of The University Of California | Removal of prions from blood, plasma and other liquids |
| US7041807B1 (en) | 1999-06-23 | 2006-05-09 | Caprion Pharmaceuticals, Inc. | Antibodies to a YYX epitope of a mammalian prion protein |
| KR20010112840A (ko) * | 2000-06-15 | 2001-12-22 | 김유삼 | 기능성 단백질의 패턴분석을 이용한 진단 시스템 |
| US6537548B1 (en) * | 2000-07-27 | 2003-03-25 | The Regents Of The University Of California | Antibodies specific for ungulate PrP |
| US6716589B2 (en) * | 2000-11-20 | 2004-04-06 | Alphabeta Ab | Discordant helix stabilization for prevention of amyloid formation |
| AUPR293801A0 (en) * | 2001-02-07 | 2001-03-01 | Novapharm Research (Australia) Pty Ltd | Prion disinfection |
| GB2376071A (en) * | 2001-05-31 | 2002-12-04 | Mini Agriculture & Fisheries | Method for typing a TSE strain |
| JP2005504289A (ja) | 2001-09-20 | 2005-02-10 | ザ・レジェンツ・オブ・ザ・ユニバーシティ・オブ・カリフォルニア | プリオンアッセイ用に調製された筋肉試料 |
| US7052849B2 (en) | 2001-11-23 | 2006-05-30 | Syn X Pharma, Inc. | Protein biopolymer markers predictive of insulin resistance |
| US20040072236A1 (en) | 2002-09-27 | 2004-04-15 | Neil Cashman | PrPSc -interacting molecules and uses thereof |
| JP5162250B2 (ja) * | 2005-01-13 | 2013-03-13 | ノバルティス バクシンズ アンド ダイアグノスティックス，インコーポレーテッド | プリオン特異的ペプチド試薬を使用するｅｌｉｓａアッセイ |
| US8293174B2 (en) | 2007-10-17 | 2012-10-23 | American Sterilizer Company | Prion deactivating composition and methods of using same |
| JP5747444B2 (ja) * | 2010-04-27 | 2015-07-15 | パナソニックヘルスケア株式会社 | βアミロイドに関連する病的状態の診断補助方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4806627A (en) * | 1987-05-29 | 1989-02-21 | Research Foundation Of Mental Hygiene Inc. | Hybrid cell lines producing monoclonal antibodies dircted against scrapie-associated fibril proteins |
| AU4376093A (en) * | 1992-05-15 | 1993-12-13 | Instituto Nazionale Neurologico C. Besta | Soluble prion polypeptides, and methods for detecting and purifying thereof |
| US5565186A (en) * | 1994-05-13 | 1996-10-15 | The Regents Of The University Of California | Method of detecting prions in a sample and transgenic animal used for same |
| US5757361A (en) * | 1996-03-20 | 1998-05-26 | International Business Machines Corporation | Method and apparatus in computer systems to selectively map tablet input devices using a virtual boundary |
| US5891641A (en) * | 1997-02-21 | 1999-04-06 | The Regents Of The University Of California | Assay for disease related conformation of a protein |
| US5977324A (en) * | 1998-02-20 | 1999-11-02 | The Regents Of The University Of California | Process for concentrating protein with disease-related conformation |
-
1999
- 1999-02-05 BR BR9908059-1A patent/BR9908059A/pt not_active IP Right Cessation
- 1999-02-05 DE DE69909442T patent/DE69909442T2/de not_active Expired - Fee Related
- 1999-02-05 DE DE1057022T patent/DE1057022T1/de active Pending
- 1999-02-05 AU AU26602/99A patent/AU753331B2/en not_active Ceased
- 1999-02-05 AT AT99906769T patent/ATE244889T1/de not_active IP Right Cessation
- 1999-02-05 KR KR1020007009182A patent/KR20010041135A/ko not_active Withdrawn
- 1999-02-05 ES ES99906769T patent/ES2203073T3/es not_active Expired - Lifetime
- 1999-02-05 EP EP99906769A patent/EP1057022B1/de not_active Expired - Lifetime
- 1999-02-05 WO PCT/US1999/002580 patent/WO1999042829A1/en not_active Ceased
- 1999-02-05 JP JP2000532720A patent/JP2003519357A/ja active Pending
- 1999-02-05 CA CA002318477A patent/CA2318477A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| JP2003519357A (ja) | 2003-06-17 |
| EP1057022A4 (de) | 2001-05-30 |
| ES2203073T3 (es) | 2004-04-01 |
| BR9908059A (pt) | 2002-01-08 |
| EP1057022A1 (de) | 2000-12-06 |
| CA2318477A1 (en) | 1999-08-26 |
| WO1999042829A1 (en) | 1999-08-26 |
| AU753331B2 (en) | 2002-10-17 |
| EP1057022B1 (de) | 2003-07-09 |
| DE69909442T2 (de) | 2004-04-22 |
| KR20010041135A (ko) | 2001-05-15 |
| DE1057022T1 (de) | 2001-10-25 |
| DE69909442D1 (de) | 2003-08-14 |
| AU2660299A (en) | 1999-09-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Kokame et al. | FRETS‐VWF73, a first fluorogenic substrate for ADAMTS13 assay | |
| DE69909442D1 (de) | Assay für spezifische stämme von mit mehreren krankheiten zusammenhängenden proteinkonformationen | |
| Krishnaswamy et al. | The binding of factor Va to phospholipid vesicles. | |
| Aharon et al. | Activation of a plant plasma membrane Ca2+ channel by TGα1, a heterotrimeric G protein α‐subunit homologue | |
| Vaculova et al. | Chapter eight caspases: determination of their activities in apoptotic cells | |
| Isfort et al. | Comparison of the standard and reduced pH Syrian hamster embryo (SHE) cell in vitro transformation assays in predicting the carcinogenic potential of chemicals | |
| ATE205884T1 (de) | Assays und vorrichtungen zum nachweis von extrahepatischer biliäreratresie | |
| ATE148230T1 (de) | Kinetische bestimmungsmethode für endotoxin unter verwendung von limulus-amoebocyten-lysat und chromogenem substrat | |
| Halliwell et al. | Electrochemical impedance spectroscopy biosensor for detection of active botulinum neurotoxin | |
| WO2006103570A2 (en) | Diagnosis method of alcoholic or non-alcoholic steato-hepatitis using biochemical markers | |
| Hassoun et al. | Procollagen C-proteinase enhancer 1 (PCPE-1) as a plasma marker of muscle and liver fibrosis in mice | |
| Louzao et al. | Detection of sodium channel activators by a rapid fluorimetric microplate assay | |
| ATE343597T1 (de) | Diagnostisches assay für typ-2-heparin induzierte thrombocytopenie | |
| DE60037864D1 (de) | Enzymhemmungsimmunverfahren | |
| DE60029413D1 (de) | Enzymatische messung von mycophenolsäure | |
| Bouman et al. | Two bone alkaline phosphatase assays compared with osteocalcin as a marker of bone formation in healthy elderly women | |
| Pastor et al. | Addressing substrate glutamine requirements for tissue transglutaminase using substance P analogues | |
| Kumar et al. | The effect of elapsed time on cardiac troponin-T (cTnT) degradation and its relation to postmortem interval in cases of electrocution | |
| Just | Methodologies and clinical utility of ADAMTS-13 activity testing | |
| WO2002035238A8 (en) | Method of determining prion strain | |
| US7550269B2 (en) | PTX3 as an early prognostic indicator of cardiovascular and cerebrovascular pathologies | |
| McNeil | The trouble with troponin | |
| Troeberg et al. | Analysis of TIMP expression and activity | |
| DE59912059D1 (de) | Verfahren zum Nachweis von Umweltverschmutzung unter Verwendung von 14-3-3 Proteinen als Biomarker | |
| EP1264897A3 (de) | Synthetisches Sensorpeptid für Kinase oder Phosphatase Assays |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |